Medivation’s Dimebon Positive In Huntington’s
This article was originally published in The Pink Sheet Daily
Executive Summary
Also in Phase III for Alzheimer’s, drug is the first to boost cognition in HD.
You may also be interested in...
Medivation’s Dimebon Shines In Alzheimer’s Open-label Extension Study
Firm recently began confirmatory Phase III; expects to file in 2010 for mild-to-moderate Alzheimer’s.
Another Hybrid License Deal: Chiesi Buys Majority Stake In Cornerstone
In a creative deal that echoes the strategic tie-up last year between Infinity and Mundipharma, Italian giant Chiesi Farmaceutici is buying a majority stake in Cornerstone Therapeutics, which gets $15.5 million along with U.S. rights for 10 years to Chiesi's marketed lung surfactant Curosurf